These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 21415284

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C, Bialer M, Falcão A, Vaz-da-Silva M, Nunes T, Almeida L, Soares-da-Silva P.
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [Abstract] [Full Text] [Related]

  • 9. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
    He YL, Zhang Y, Serra D, Wang Y, Ligueros-Saylan M, Dole WP.
    Curr Med Res Opin; 2011 Jul; 27(7):1453-63. PubMed ID: 21609207
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study.
    Pinto R, l'Hostis P, Patat A, Homery MC, Falcão A, Nunes T, Rocha JF, Soares-da-Silva P.
    Clin Pharmacol Drug Dev; 2015 Nov; 4(6):454-62. PubMed ID: 27137718
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lacosamide cardiac safety: a thorough QT/QTc trial in healthy volunteers.
    Kropeit D, Johnson M, Cawello W, Rudd GD, Horstmann R.
    Acta Neurol Scand; 2015 Nov; 132(5):346-54. PubMed ID: 25932544
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.
    Kori S, Kellerman DJ, Voloshko P, Haugen G.
    Clin Ther; 2012 Sep; 34(9):1920-8. PubMed ID: 22917853
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women.
    Stier B, Fossler M, Liu F, Caltabiano S.
    Clin Ther; 2015 Jul 01; 37(7):1541-54. PubMed ID: 26138866
    [Abstract] [Full Text] [Related]

  • 18. Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals.
    Hoch M, Darpo B, Brossard P, Zhou M, Stoltz R, Dingemanse J.
    Basic Clin Pharmacol Toxicol; 2015 May 01; 116(5):429-37. PubMed ID: 25287214
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
    Nunes T, Sicard E, Almeida L, Falcão A, Rocha JF, Brunet JS, Lefebvre M, Soares-da-Silva P.
    Curr Med Res Opin; 2010 Jun 01; 26(6):1355-62. PubMed ID: 20377319
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.